Alnylam Pharmaceuticals (ALNY) News Today $331.94 +2.17 (+0.66%) Closing price 07/3/2025 03:39 PM EasternExtended Trading$331.94 0.00 (0.00%) As of 07/3/2025 04:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock ALNY Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period Strategic Financial Concepts LLC Has $203,000 Stake in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)July 5 at 5:09 AM | marketbeat.comAlnylam Pharmaceuticals (NASDAQ:ALNY) Upgraded at Wall Street ZenJuly 5 at 2:18 AM | marketbeat.comSumitomo Mitsui DS Asset Management Company Ltd Acquires 1,346 Shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)July 4 at 4:45 AM | marketbeat.comMirae Asset Global Investments Co. Ltd. Has $1.76 Million Stock Position in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)July 4 at 3:47 AM | marketbeat.comALNY - Alnylam Pharmaceuticals Inc Key Metrics - MorningstarJuly 3 at 6:28 PM | morningstar.comMHepatitis D Pipeline Appears Robust With 8+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsightJuly 3 at 6:28 PM | theglobeandmail.comAlnylam's Norton site is 'springboard' for expanding manufacturing capacityJuly 2 at 9:04 AM | bizjournals.comAlnylam Pharmaceuticals (NASDAQ:ALNY) Sets New 52-Week High After Analyst UpgradeJuly 2 at 2:27 AM | americanbankingnews.comSumitomo Mitsui Trust Group Inc. Has $78.70 Million Holdings in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)July 1, 2025 | marketbeat.comDiversified Trust Co Sells 999 Shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)July 1, 2025 | marketbeat.comAlnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Shares Sold by Envestnet Portfolio Solutions Inc.July 1, 2025 | marketbeat.comAlnylam Pharmaceuticals (NASDAQ:ALNY) Stock Price Expected to Rise, Wells Fargo & Company Analyst SaysJuly 1, 2025 | americanbankingnews.comAlnylam Pharmaceuticals (NASDAQ:ALNY) Reaches New 1-Year High After Analyst UpgradeJune 30, 2025 | marketbeat.comAlnylam Pharmaceuticals (NASDAQ:ALNY) Price Target Raised to $333.00June 30, 2025 | marketbeat.com788 Shares in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Bought by Essex LLCJune 30, 2025 | marketbeat.comBMO Capital Maintains ‘Outperform’ Rating on Alnylam Pharmaceuticals, Inc. (ALNY); Raises PTJune 29, 2025 | insidermonkey.comAllspring Global Investments Holdings LLC Buys New Position in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)June 29, 2025 | marketbeat.comPerpetual Ltd Decreases Position in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)June 29, 2025 | marketbeat.comAlnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Receives Consensus Rating of "Moderate Buy" from AnalystsJune 29, 2025 | marketbeat.comAlnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Position Increased by Robeco Institutional Asset Management B.V.June 28, 2025 | marketbeat.comAlnylam Pharmaceuticals (NASDAQ:ALNY) Stock Price Expected to Rise, Needham & Company LLC Analyst SaysJune 28, 2025 | americanbankingnews.com1,709 Shares in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Bought by Lecap Asset Management Ltd.June 27, 2025 | marketbeat.comWealth Enhancement Advisory Services LLC Has $3.89 Million Stock Position in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)June 27, 2025 | marketbeat.comJ.P. Morgan Sticks to Its Sell Rating for Nektar Therapeutics (NKTR)June 26, 2025 | theglobeandmail.comAlnylam Pharma (ALNY) Gets a Buy from BMO CapitalJune 26, 2025 | theglobeandmail.comAlnylam Pharmaceuticals (NASDAQ:ALNY) Price Target Raised to $377.00 at Needham & Company LLCJune 26, 2025 | marketbeat.comArchford Capital Strategies LLC Acquires Shares of 2,019 Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)June 26, 2025 | marketbeat.comAsset Management One Co. Ltd. Acquires 3,094 Shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)June 26, 2025 | marketbeat.comAlnylam Pharmaceuticals (NASDAQ:ALNY) Given New $360.00 Price Target at BMO Capital MarketsJune 25, 2025 | americanbankingnews.comAlnylam Pharmaceuticals (ALNY) Price Target Raised by BMO Capital | ALNY Stock NewsJune 24, 2025 | gurufocus.comBMO Capital Markets Increases Alnylam Pharmaceuticals (NASDAQ:ALNY) Price Target to $360.00June 24, 2025 | marketbeat.comAlnylam Pharmaceuticals (NASDAQ:ALNY) Hits New 52-Week High - Time to Buy?June 24, 2025 | marketbeat.comKentucky Retirement Systems Insurance Trust Fund Makes New $1.01 Million Investment in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)June 24, 2025 | marketbeat.comKentucky Retirement Systems Buys New Shares in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)June 24, 2025 | marketbeat.comQRG Capital Management Inc. Raises Stock Position in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)June 23, 2025 | marketbeat.comAlnylam Pharmaceuticals (NasdaqGS:ALNY) Appoints New R&D Chief to Drive Growth PhaseJune 20, 2025 | finance.yahoo.comAlnylam names Pushkal Garg as EVP, chief research and development officerJune 19, 2025 | finance.yahoo.comAlnylam Pharma Appoints New Chief R&D OfficerJune 18, 2025 | tipranks.comAlnylam Pharmaceuticals (NASDAQ:ALNY) Hits New 12-Month High - Here's WhyJune 18, 2025 | marketbeat.comAlnylam Pharmaceuticals Names Garg R&D ChiefJune 18, 2025 | marketwatch.comAlnylam Announces Promotion of Pushkal Garg to Chief Research and Development OfficerJune 18, 2025 | businesswire.comAssenagon Asset Management S.A. Reduces Holdings in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)June 18, 2025 | marketbeat.comNorthCrest Asset Manangement LLC Makes New Investment in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)June 16, 2025 | marketbeat.comRBC Capital Remains a Buy on Alnylam Pharma (ALNY)June 15, 2025 | theglobeandmail.comAlnylam Pharmaceuticals' SWOT analysis: stock poised for growth in expanding ATTR-CM marketJune 14, 2025 | investing.comAlnylam Pharmaceuticals (NASDAQ:ALNY) Downgraded by Wall Street Zen to HoldJune 14, 2025 | marketbeat.comTobam Sells 8,418 Shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)June 13, 2025 | marketbeat.comWhat 18 Analyst Ratings Have To Say About Alnylam PharmaceuticalsJune 12, 2025 | benzinga.comAlnylam Pharmaceuticals (NASDAQ:ALNY) Given New $338.00 Price Target at JPMorgan Chase & Co.June 12, 2025 | marketbeat.comThe European Commission Approves Alnylam’s AMVUTTRAJune 11, 2025 | msn.com Get Alnylam Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for ALNY and its competitors with MarketBeat's FREE daily newsletter. Email Address ALNY Media Mentions By Week ALNY Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ALNY News Sentiment▼0.980.57▲Average Medical News Sentiment ALNY News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ALNY Articles This Week▼2016▲ALNY Articles Average Week Get Alnylam Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for ALNY and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Amgen News Gilead Sciences News Vertex Pharmaceuticals News Regeneron Pharmaceuticals News Biogen News Incyte News United Therapeutics News Neurocrine Biosciences News Exelixis News BioMarin Pharmaceutical News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ALNY) was last updated on 7/5/2025 by MarketBeat.com Staff From Our PartnersPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredA grave, grave error.Famed financial analyst, Porter Stansberry, calls this technology “The Final Frontier” because it holds the ke...Porter & Company | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alnylam Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Alnylam Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
